The emergence of the best and the worst stocks at the same time makes the fund’s position on the medical track a double day of sorrow and joy.
Affected by the covid-19 epidemic, a number of stocks in the medical track had significant stock price changes driven by events, including fund heavy position stocks Xi’An International Medical Investment Company Limited(000516) and fund unique stocks Andon Health Co.Ltd(002432) . The Securities Times reporter noted that a number of fund companies have lowered the valuation of Xi’An International Medical Investment Company Limited(000516) to 7.11 yuan, which means that the fund’s heavy position stocks will face no small room for decline. When the fund’s heavy position stocks Xi’An International Medical Investment Company Limited(000516) were severely lowered by the fund, a small-scale fund company or its unique stocks earned a profit of 1.3 billion yuan in four months.
Xi’An International Medical Investment Company Limited(000516) was downgraded by several funds
Affected by the suspension of business for rectification and stock st, several funds announced a reduction in Xi’An International Medical Investment Company Limited(000516) valuation over the weekend.
CITIC Prudential fund disclosed at the weekend that, according to relevant regulations and through consultation with the fund custodian, the fund company decided to value Xi’An International Medical Investment Company Limited(000516) (000516) held by its securities investment fund at 7.18 yuan / share from January 14, 2022.
The above-mentioned funds said that they would pay close attention to the follow-up developments of Xi’An International Medical Investment Company Limited(000516) and adjust their valuation prices in time if necessary. From the date when the above stock transactions reflect the trading characteristics of the active market, the company will comprehensively refer to various relevant influencing factors and negotiate with the fund custodian to determine to resume using the closing price of the day for valuation, and no further announcement will be made at that time.
Compared with the valuation of RMB 7.18, Jinying fund adjusted the valuation of Xi’An International Medical Investment Company Limited(000516) lower. On the same day, Jinying Fund announced that in order to make the valuation of relevant funds under the fund manager fair and reasonable, according to the Xi’An International Medical Investment Company Limited(000516) suggestive public notice on other risks warning and suspension of the company’s shares issued on January 13, 2022, From January 14, 2022, the fund manager revalued Xi’An International Medical Investment Company Limited(000516) held by its securities investment fund, and the valuation price was adjusted to RMB 7.11.
Before the above announcement, as of January 13, Xi’An International Medical Investment Company Limited(000516) closed at 8.37 yuan, and the lowest valuation adjustment of 7.11 yuan means that the fund expects the stock to fall another 15%. In addition to Golden Eagle Fund and CITIC Prudential fund, GF fund and BOC fund with a position of Xi’An International Medical Investment Company Limited(000516) also issued relevant announcements earlier, and the valuation price adjustment of Xi’An International Medical Investment Company Limited(000516) was 7.11 yuan.
Although only four public offerings with positions of Xi’An International Medical Investment Company Limited(000516) issued valuation reduction announcements before the deadline, other companies with positions in the stock may follow up and reduce the valuation of Xi’An International Medical Investment Company Limited(000516) in the future. According to the periodic report disclosed by Xi’An International Medical Investment Company Limited(000516) , as of the end of the third quarter of last year, 22 funds under 9 public offerings held Xi’An International Medical Investment Company Limited(000516) 132 million shares in total, with a market value of 1.498 billion yuan, accounting for about 7% of the circulating shares.
The reporter of the Securities Times noted that as a star company in the field of assisted reproduction, Xi’An International Medical Investment Company Limited(000516) has always attracted financial attention. In the first quarter of last year, they obtained the research of top flow fund managers Zhou Yingbo and Zhang Kun. However, according to the disclosed position information, the two top flow public offerings seem to have nothing to do with Xi’An International Medical Investment Company Limited(000516) after the research.
can you get the floating profit of 1.3 billion in three months?
While Xi’An International Medical Investment Company Limited(000516) was tragically downgraded by the fund, Andon Health Co.Ltd(002432) recently enjoyed a four-day limit, which made the stock rise more than 10 times in two and a half months.
After the share price soared 10 times in a short time, Andon Health Co.Ltd(002432) recently announced that its U.S. subsidiary ihealth labs Inc and ACC (U.S. Army contracting command) signed a procurement contract on January 13, 2022 local time and came into force.
According to the contents of the contract, the total amount of contract price and tax is as high as US $1.275 billion, or 8.102 billion yuan. This figure far exceeds Andon Health Co.Ltd(002432) the revenue level of 790 million yuan in the first three quarters of 2021 and significantly exceeds its revenue in 2020.
The reporter of the Securities Times noted that Andon Health Co.Ltd(002432) is a typical unique fund stock. According to the disclosed information of the stock, as of the end of the third quarter of last year, only one fund company appeared on the list of the top ten shareholders of the stock. A special account under Beixin Ruifeng fund company held Andon Health Co.Ltd(002432) 1971 million shares by the end of the reporting period, accounting for 4.12% of the total share capital, Beixin Ruifeng fund is the second largest shareholder of the stock.
Based on the closing price of 6.69 yuan at the end of the third quarter of last year when Beixin Ruifeng fund bought the stock, the market value of Andon Health Co.Ltd(002432) held by the fund is about 132 million yuan, and the current share price of Andon Health Co.Ltd(002432) is as high as 75.28 yuan / share. If Beixin Ruifeng fund does not cash in, the market value of Andon Health Co.Ltd(002432) held by the fund company will be as high as 1.484 billion, which also means that, Beixin Ruifeng fund company will make a profit of at least 1.3 billion in one stock, which is comparable to pie in the sky for a mini fund company with a scale of less than 10 billion.
However, after the stock price achieved an amazing rise in a short time, the risk factors of the high stock price and the smooth implementation of orders also began to attract capital attention. On January 16, Andon Health Co.Ltd(002432) disclosed the abnormal fluctuation of stock trading and risk warning. It showed that during the execution of contracts and orders between the company’s U.S. subsidiaries and New York, Massachusetts and HHS (executed by the American ACC representative), the company was affected by changes in local epidemic situation, changes in policies, changes in the company’s supply chain capacity Under the influence of logistics and transportation risks, unpredictable or force majeure and other factors, there may be a risk that the contract or order can not be performed on schedule or in full.
Andon Health Co.Ltd(002432) also said that it should be noted that the U.S. government has the right to terminate the contract signed between the company’s U.S. subsidiary and U.S. HHS (executed by the U.S. ACC representative) at any time due to its own factors. There is uncertainty whether the contract can be fully implemented.
Obviously, it is difficult to determine whether Beixin Ruifeng fund, which has already got on the bus, can really eat meat in front of ten times the shares. In addition, relevant companies have just issued risk warning announcements on order implementation, which may also increase the difficulty of fund cashing.
